Sean Sullivan
Seminars
Thursday 2nd January 2025
Leveraging the LUNAR® Platform to Develop RNA Medicines for Diseases with Significant Unmet Medical Needs & Accelerated Clinical Paths
12:15 pm
- Overview of the ARCT-032 program – an mRNA replacement therapy to deliver a new copy of the CFTR mRNA into CF patients’ airways
- Overview of the ARCT-810 Program – an mRNA medicine that enables OTC patients to make healthy functional OTC enzymes in their liver cells
- ARCT-154 demonstrates non-inferiority to original strain and superior immunogenicity to Omicron BA.4/5 variant compared to a first-generation mRNA vaccine booster
